In addition, we measured the IC50 of other chemotherapeutic and targeted drugs, and the results showed that LINC01764 did not affect the drug sensitivity of CRC cells to CPT‐11, cisplatin, and regorafenib (Figure S2). The gene discussed is UCA1-AS1; the disease is colorectal carcinoma.